Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 103, Issue 11, Pages 1698-1705
Publisher
Springer Nature
Online
2010-11-24
DOI
10.1038/sj.bjc.6605866
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vascular endothelial growth factor-targeted therapy in metastatic renal cell carcinoma
- (2010) Brian I. Rini CANCER
- Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway
- (2010) Yanbin Zhao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma
- (2009) Andréia Hanada Otake et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy
- (2009) Stefan Wilop et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Angiotensin II Regulates the Expression of Monocyte Chemoattractant Protein-1 in Pancreatic Cancer Cells
- (2009) Navdeep Chehl et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET
- (2009) S. Negrier et al. MEDICAL ONCOLOGY
- AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist
- (2009) D. R. Rhodes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor
- (2009) Sudeep K. Bose et al. PROSTATE
- Angiotensin II Type 1 Receptor Antagonist Enhances Cis-dichlorodiammineplatinum-Induced Cytotoxicity in Mouse Xenograft Model of Bladder Cancer
- (2009) Michio Kosugi et al. UROLOGY
- Blockade of an angiotensin type I receptor enhances effects of radiation on tumor growth and tumor-associated angiogenesis by reducing vascular endothelial growth factor expression
- (2008) Yuichiro Ohnuma et al. BIOMEDICINE & PHARMACOTHERAPY
- Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis
- (2008) O Arrieta et al. BRITISH JOURNAL OF CANCER
- Potential role of Renin–Angiotensin-system for tumor angiogenesis in receptor negative breast cancer
- (2008) D. Herr et al. GYNECOLOGIC ONCOLOGY
- Favorable response to combination treatment of cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin system inhibitor in metastatic renal cell carcinoma: Report of three cases
- (2008) Manabu Tatokoro et al. INTERNATIONAL JOURNAL OF UROLOGY
- Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206
- (2008) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Specific single chain variable fragment (ScFv) antibodies to angiotensin II AT2 receptor: evaluation of the angiotensin II receptor expression in normal and tumor-bearing mouse lung
- (2008) Masaaki Tamura et al. JOURNAL OF MOLECULAR HISTOLOGY
- Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: A new role in the treatment of leukaemia for these agents
- (2008) Silvia De la Iglesia Iñigo et al. LEUKEMIA RESEARCH
- Role of Bradykinin, Nitric Oxide, and Angiotensin II Type 2 Receptor in Imidapril-Induced Angiogenesis
- (2007) Ping Li et al. HYPERTENSION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now